Matches in Wikidata for { <http://www.wikidata.org/entity/Q95837500> ?p ?o ?g. }
Showing items 1 to 39 of
39
with 100 items per page.
- Q95837500 description "article scientifique publié en 2020" @default.
- Q95837500 description "artículu científicu espublizáu en mayu de 2020" @default.
- Q95837500 description "im Mai 2020 veröffentlichter wissenschaftlicher Artikel" @default.
- Q95837500 description "scientific article published on 25 May 2020" @default.
- Q95837500 description "wetenschappelijk artikel" @default.
- Q95837500 description "наукова стаття, опублікована 25 травня 2020" @default.
- Q95837500 name "Comparison of safety, efficacy and cost between oral pulse cyclophosphamide versus intravenous cyclophosphamide pulse therapy in severe systemic lupus erythematosus" @default.
- Q95837500 name "Comparison of safety, efficacy and cost between oral pulse cyclophosphamide versus intravenous cyclophosphamide pulse therapy in severe systemic lupus erythematosus" @default.
- Q95837500 type Item @default.
- Q95837500 label "Comparison of safety, efficacy and cost between oral pulse cyclophosphamide versus intravenous cyclophosphamide pulse therapy in severe systemic lupus erythematosus" @default.
- Q95837500 label "Comparison of safety, efficacy and cost between oral pulse cyclophosphamide versus intravenous cyclophosphamide pulse therapy in severe systemic lupus erythematosus" @default.
- Q95837500 prefLabel "Comparison of safety, efficacy and cost between oral pulse cyclophosphamide versus intravenous cyclophosphamide pulse therapy in severe systemic lupus erythematosus" @default.
- Q95837500 prefLabel "Comparison of safety, efficacy and cost between oral pulse cyclophosphamide versus intravenous cyclophosphamide pulse therapy in severe systemic lupus erythematosus" @default.
- Q95837500 P1433 Q95837500-8D3BB399-E4FE-4C5F-A04F-44635505E4EF @default.
- Q95837500 P1476 Q95837500-E03445BC-D87D-4446-BFCC-1D524ED64490 @default.
- Q95837500 P2093 Q95837500-2696CF39-C7F9-40DD-B3DF-1A786C76B02A @default.
- Q95837500 P2093 Q95837500-56FF664F-261F-4C0F-8C7A-5BA5E958D752 @default.
- Q95837500 P2093 Q95837500-7B94A97B-2CEA-4058-9F3D-AC93490441D0 @default.
- Q95837500 P2093 Q95837500-D07DED45-64F3-4223-8D68-FDCDF7F224F9 @default.
- Q95837500 P31 Q95837500-4D14CCAD-37AA-4658-8050-81B493744A24 @default.
- Q95837500 P356 Q95837500-EBF356C6-8FB9-4F5F-A52D-E9681921E05B @default.
- Q95837500 P50 Q95837500-46564610-23B8-40F3-9D0B-E3E5D38A4533 @default.
- Q95837500 P577 Q95837500-1BFC37EF-600E-4BDC-9A15-97EDA4CA1AF4 @default.
- Q95837500 P698 Q95837500-408ACBA6-B4B8-4A51-984E-24616700BA1C @default.
- Q95837500 P921 Q95837500-A78F4960-F0DF-4366-AB23-5D5B05371625 @default.
- Q95837500 P356 1756-185X.13823 @default.
- Q95837500 P698 32452167 @default.
- Q95837500 P1433 Q15764244 @default.
- Q95837500 P1476 "Comparison of safety, efficacy and cost between oral pulse cyclophosphamide versus intravenous cyclophosphamide pulse therapy in severe systemic lupus erythematosus" @default.
- Q95837500 P2093 "Ajit Surin" @default.
- Q95837500 P2093 "Debashish Danda" @default.
- Q95837500 P2093 "Suvrat Arya" @default.
- Q95837500 P2093 "Vishad Viswanath" @default.
- Q95837500 P31 Q13442814 @default.
- Q95837500 P356 "10.1111/1756-185X.13823" @default.
- Q95837500 P50 Q95837498 @default.
- Q95837500 P577 "2020-05-25T00:00:00Z" @default.
- Q95837500 P698 "32452167" @default.
- Q95837500 P921 Q1485 @default.